215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands.

51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The Netherlands.

193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands.

The 193rd ENMC International Workshop brought together 21 researchers from nine countries: Belgium, Finland, France, Germany, The Netherlands, Spain, Sweden, United Kingdom, and United States of America. The group was joined by a patient representative from the Dutch working group of myositis patients. The participants discussed the idiopathic inflammatory myopathies (IIM), that comprise a numb...

170th ENMC International Workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27-29 November 2009, Naarden, The Netherlands.

The first ENMC workshop for bone protection in DMD patients treated with corticosteroids included 18 participants from Europe, USA and Canada. The participants were from diverse backgrounds including Paediatric Neurology, Endocrinology, Metabolic bone disease, Orthopaedics and Medical Physics. The objectives of the workshop were to discuss the problem of vertebral fractures with the following a...

A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy

The discovery of effective therapies and of disease mechanisms underlying valosin containing protein (VCP)-associated myopathies and neurodegenerative disorders remains elusive. VCP disease, caused by mutations in the VCP gene, are a clinically and genetically heterogeneous group of disorders with manifestations varying from hereditary inclusion body myopathy, Paget's disease of bone, frontotem...

171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy.

An ENMC workshop on standards of care and management of facioscapulohumeral muscular dystrophy (FSHD) patients was held on January 15–17, 2010 in Naarden, The Netherlands. Twenty-four participants from eight countries participated. The primary objective was to develop standards of care in the diagnosis and management of patients with FSHD. Recommendations were formulated based on evidence, when...